TrialPloS one2015

The hypolipidemic and pleiotropic effects of rosuvastatin are not enhanced by its association with zinc and selenium supplementation in coronary artery disease patients: a double blind randomized controlled study.

Karine Cavalcanti Maurício Sena-Evangelista et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.